A multi-tenant computational platform for translational medicine

被引:0
作者
Oehmichen, Axel [1 ]
Guitton, Florian [1 ]
Agapow, Paul [1 ]
Emam, Ibrahim [1 ]
Guo, Yike [1 ]
机构
[1] Imperial Coll London, Data Sci Inst, London SW7 2AZ, England
来源
2018 IEEE 38TH INTERNATIONAL CONFERENCE ON DISTRIBUTED COMPUTING SYSTEMS (ICDCS) | 2018年
关键词
D O I
10.1109/ICDCS.2018.00167
中图分类号
TP3 [计算技术、计算机技术];
学科分类号
0812 ;
摘要
Translational biomedical research has become a science driven by big data. Improving patient care by developing personalized therapies and new drugs depends increasingly on an organization's ability to rapidly and intelligently leverage complex molecular and clinical data from a variety of largescale internal and external, partner and public, data sources. As analysing these large-scale and complex datasets has become increasingly computationally expensive, it is of paramount importance to enable researchers to seamlessly scale up their computation platform while being able to manage complex yet flexible scenario that biomedical scientists are asking for. We developed a new platform as an answer to those needs of analysing and exploring massive amounts of medical data with the constrain of enabling the broadest audience, ranging from the medical doctor to the advanced coders, to easily and intuitively exploit this new resource. The platform consists of three main components: Borderline UI, the eTRIKS Analytical Environment (eAE)(1) [I] and the eTRIKS Data Platform (eDP). Each component has been designed to operate on specific sets of problems statelessly, developed as independent open-source software packages, and connected loosely in a cloud-native fashion [2] to form a coherent platform for large scale medical data analysis. The code is fully open source and available on GitHub at this address: https://github.com/dsi-icl
引用
收藏
页码:1553 / 1556
页数:4
相关论文
共 18 条
[1]  
Abrahams E., 2008, CLIN TRANSLATIONAL S
[2]  
Ailem M., 2015, 24 ACM C INF KNOWL M
[3]  
[Anonymous], EUROPEAN RESP J
[4]  
[Anonymous], HLTH POLICY TECHNOLO
[5]   Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine [J].
Bayani, Jane ;
Yao, Cindy Q. ;
Quintayo, Mary Anne ;
Yan, Fu ;
Haider, Syed ;
D'Costa, Alister ;
Brookes, Cassandra L. ;
van de Velde, Cornelis J. H. ;
Hasenburg, Annette ;
Kieback, Dirk G. ;
Markopoulos, Christos ;
Dirix, Luc ;
Seynaeve, Caroline ;
Rea, Daniel ;
Boutros, Paul C. ;
Bartlett, John M. S. .
NPJ BREAST CANCER, 2017, 3
[6]  
Gannon D., 2017, IEEE CLOUD COMPUTING
[7]  
Kuo C.-H. S., 2017, EUROPEAN RESP J
[8]  
Lee C.H., 2017, Kidney Research and Clinical Practice
[9]  
Merkel D., 2014, LINUX J, DOI DOI 10.5555/2600239.2600241
[10]  
Oehmichen A, 2017, IEEE INT CONF BIG DA, P353, DOI 10.1109/BigData.2017.8257945